Weight-Loss Drug Fights Alcoholic Fatty Liver Disease

Related Encyclopedia • Abdominoplasty • Acidophilus • Adenocarcinoma of the Lung and Brain Metastases • Ankle Sprains More... Related Healthscout Videos Complementary Cancer Care A Welcome Message from Survivor PJ Hamel Smother Says "Cut!" Maryann and Paula More... Related Animations • Breast Self-Exam Video • Colon Cancer • Hepatitis • What is Cholesterol? More... Related Drug Information • Epogen • Iressa • Klor-Con • Klor-Con ER More... Related News Articles • Cancer Death Rates Decline Among Blacks, But Disparities Linger • Genetic Mutations Linked to Deadly Brain Cancer • Many Clinical Trials Moving Overseas • Sunken, Unexploded Bombs Pose Cancer Risk More...

Page:  << Prev | 1 | 2

Drugs that selectively act on CB1 receptors found outside of the brain might help fight fatty liver with less risk of side effects such as anxiety and depression, they said.

"Rimonabant has recently been introduced in Europe for the treatment of visceral obesity and the metabolic syndrome, which themselves are known risk factors for [liver disease]. Clinical trials testing the effectiveness of CB1 receptor blockers in the treatment of both alcoholic and nonalcoholic fatty liver and their more severe sequelae may be warranted," the researchers concluded.

More information

Text Continues Below

---

The American Liver Foundation has more about fatty liver.

Page:  << Prev | 1 | 2

-- Robert Preidt